Otrivin Menthol 0.1% nasal spray

Otrivin is a globally recognized brand of nasal decongestant products containing xylometazoline. The brand has a long history, originally established by the Swiss pharmaceutical giant Ciba (later Ciba-Geigy and eventually Novartis).

Starting in 2022, Otrivin became part of Haleon, a leading global consumer healthcare company that was formed following the demerger of GlaxoSmithKline's (GSK) consumer health division. The product shown in the image is marketed specifically for the Central European market, as indicated by the Slovak/Czech labeling 'nosový roztokový sprej'.

Most Otrivin production for the European market occurs at high-tech pharmaceutical manufacturing sites in Switzerland, though the brand operates within a global supply chain under the Haleon umbrella.